RAF1 kinase activity is dispensable for KRAS/p53 mutant lung tumor progression

被引:21
作者
Sanclemente, Manuel [1 ]
Nieto, Patricia [1 ,4 ]
Garcia-Alonso, Sara [1 ]
Fernandez-Garcia, Fernando [1 ]
Esteban-Burgos, Laura [1 ]
Guerra, Carmen [1 ]
Drosten, Matthias [1 ]
Caleiras, Eduardo [2 ]
Martinez-Torrecuadrada, Jorge [3 ]
Santamaria, David [1 ,5 ]
Musteanu, Monica [1 ,6 ]
Barbacid, Mariano [1 ]
机构
[1] Ctr Nacl Invest Oncol, Mol Oncol, Melchor Fernandez Almagro 3, Madrid 28029, Spain
[2] Ctr Nacl Invest Oncol, Biotechnol, Melchor Fernandez Almagro 3, Madrid 28029, Spain
[3] Ctr Nacl Invest Oncol, Struct Biol Programs, Melchor Fernandez Almagro 3, Madrid 28029, Spain
[4] Asociac Espanola Canc AECC, Madrid 28040, Spain
[5] Univ Bordeaux, INSERM, U1218, ACTION Lab,IECB, F-33607 Pessac, France
[6] Univ Complutense Madrid, Dept Biochem & Mol Biol, Fac Pharm, Madrid, Spain
基金
欧洲研究理事会;
关键词
C-RAF; REGRESSION; APOPTOSIS;
D O I
10.1016/j.ccell.2021.01.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:294 / 296
页数:3
相关论文
共 10 条
[1]   c-Raf, but Not B-Raf, Is Essential for Development of K-Ras Oncogene-Driven Non-Small Cell Lung Carcinoma [J].
Blasco, Rafael B. ;
Francoz, Sarah ;
Santamaria, David ;
Canamero, Marta ;
Dubus, Pierre ;
Charron, Jean ;
Baccarini, Manuela ;
Barbacid, Mariano .
CANCER CELL, 2011, 19 (05) :652-663
[2]   Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism [J].
Chen, J ;
Fuji, K ;
Zhang, LX ;
Roberts, T ;
Fu, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (14) :7783-7788
[3]   Targeting the MAPK Pathway in KRAS-Driven Tumors [J].
Drosten, Matthias ;
Barbacid, Mariano .
CANCER CELL, 2020, 37 (04) :543-550
[4]   Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomas [J].
Esteban-Burgos, Laura ;
Wang, Haiyun ;
Nieto, Patricia ;
Zheng, Jie ;
Blanco-Aparicio, Carmen ;
Varela, Carmen ;
Gomez-Lopez, Gonzalo ;
Fernandez-Garcia, Fernando ;
Sanclemente, Manuel ;
Guerra, Carmen ;
Drosten, Matthias ;
Galan, Javier ;
Caleiras, Eduardo ;
Martinez-Torrecuadrada, Jorge ;
Fajas, Lluis ;
Peng, Sheng-Bin ;
Santamaria, David ;
Musteanu, Monica ;
Barbacid, Mariano .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (39) :24415-24426
[5]   Induced protein degradation: an emerging drug discovery paradigm [J].
Lai, Ashton C. ;
Crews, Craig M. .
NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (02) :101-114
[6]   CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation [J].
Noble, Catherine ;
Mercer, Kathryn ;
Hussain, Jahan ;
Carragher, Linda ;
Giblett, Susan ;
Hayward, Robert ;
Patterson, Cam ;
Marais, Richard ;
Pritchard, Catrin A. .
MOLECULAR CELL, 2008, 31 (06) :862-872
[7]   Rote of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1 [J].
O'Neill, E ;
Rushworth, L ;
Baccarini, M ;
Kolch, W .
SCIENCE, 2004, 306 (5705) :2267-2270
[8]   K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions [J].
Ostrem, Jonathan M. ;
Peters, Ulf ;
Sos, Martin L. ;
Wells, James A. ;
Shokat, Kevan M. .
NATURE, 2013, 503 (7477) :548-+
[9]   c-RAF Ablation Induces Regression of Advanced Kras/Trp53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling [J].
Sanclemente, Manuel ;
Francoz, Sarah ;
Esteban-Burgos, Laura ;
Bousquet-Mur, Emilie ;
Djurec, Magdolna ;
Lopez-Casas, Pedro P. ;
Hidalgo, Manuel ;
Guerra, Carmen ;
Drosten, Matthias ;
Musteanu, Monica ;
Barbacid, Mariano .
CANCER CELL, 2018, 33 (02) :217-+
[10]   Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF [J].
Teresa Blasco, Maria ;
Navas, Carolina ;
Martin-Serrano, Guillermo ;
Grana-Castro, Osvaldo ;
Lechuga, Carmen G. ;
Martin-Diaz, Laura ;
Djurec, Magdolna ;
Li, Jing ;
Morales-Cacho, Lucia ;
Esteban-Burgos, Laura ;
Perales-Paton, Javier ;
Bousquet-Mur, Emilie ;
Castellano, Eva ;
Jacob, Harrys K. C. ;
Cabras, Lavinia ;
Musteanu, Monica ;
Drosten, Matthias ;
Ortega, Sagrario ;
Mulero, Francisca ;
Sainz Jr, Bruno ;
Dusetti, Nelson ;
Iovanna, Juan ;
Sanchez-Bueno, Francisco ;
Hidalgo, Manuel ;
Khiabanian, Hossein ;
Rabadan, Raul ;
Al-Shahrour, Fatima ;
Guerra, Carmen ;
Barbacid, Mariano .
CANCER CELL, 2019, 35 (04) :573-+